Dean’s Report

WELCOME TO THE latest issue of the Dean’s Report, where we highlight recent breakthroughs at the Icahn School of Medicine at Mount Sinai. Each article is a testament to Mount Sinai’s relentless drive to advance science and medicine in order to improve the health of our patients.

Read how a popular anticonvulsant drug may be effective in treating depression and how blocking the survival mechanism of senescent cells may help treat Langerhans-cell histiocytosis. Learn about Mount Sinai's low-cost COVID-19 vaccine, which can be manufactured in the same facilities as influenza vaccines, and how a recent discovery in one of our labs may bring relief to patients with treatment-resistant Crohn's disease. We also explain how our genomics experts are using Mount Sinai's extensive biobank of diverse patient samples and electronic health records to study whether ancestral genes predict disease susceptibility.